baclofen has been researched along with Action Tremor in 20 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Harmaline-induced tremor in rodents is a model of essential tremor." | 7.75 | Pharmacological characterization of harmaline-induced tremor activity in mice. ( Foreman, MM; Hanania, T; Malekiani, SA; Olivier, B; Paterson, NE, 2009) |
| "The authors present the case of a 49-year-old woman with disabling bilateral upper-extremity cerebellar tremor that resolved unexpectedly after placement of an intrathecal baclofen pump for lower-extremity spasticity." | 7.72 | Attenuation of cerebellar tremor with implantation of an intrathecal baclofen pump: the role of gamma-aminobutyric acidergic pathways. Case report. ( Lenz, FA; North, RB; Ohara, S; Weiss, N, 2003) |
| "Recent experimental and clinical studies clearly suggest the role of gamma-aminobutyric acid (GABA) in the pathogenesis of tremors." | 7.71 | Baclofen attenuates harmaline induced tremors in rats. ( Al Deeb, S; Al Moutaery, K; Arshaduddin, M; Biary, N; Tariq, M, 2001) |
| "A Parkinsonian-like tremor can be induced by a combined application of chlorpromazine and pentobarbitone in cats." | 7.68 | Parkinsonian-like tremor induced by a combined application of chlorpromazine and pentobarbitone in cats with left-paw preference. ( Cankaya, A; Gepdiremen, A; Kutlu, N; Tan, U, 1992) |
| "Symptomatic treatment of Multiple Sclerosis (MS) is crucial, since it helps to lessen the limitations that affect patients' daily lives." | 5.91 | Effects of intrathecal Baclofen in reducing tremors in patients with multiple sclerosis. ( Aldarwish, WA; Ali, EN, 2023) |
| "Harmaline-induced tremor in rodents is a model of essential tremor." | 3.75 | Pharmacological characterization of harmaline-induced tremor activity in mice. ( Foreman, MM; Hanania, T; Malekiani, SA; Olivier, B; Paterson, NE, 2009) |
| "The authors present the case of a 49-year-old woman with disabling bilateral upper-extremity cerebellar tremor that resolved unexpectedly after placement of an intrathecal baclofen pump for lower-extremity spasticity." | 3.72 | Attenuation of cerebellar tremor with implantation of an intrathecal baclofen pump: the role of gamma-aminobutyric acidergic pathways. Case report. ( Lenz, FA; North, RB; Ohara, S; Weiss, N, 2003) |
| "Recent experimental and clinical studies clearly suggest the role of gamma-aminobutyric acid (GABA) in the pathogenesis of tremors." | 3.71 | Baclofen attenuates harmaline induced tremors in rats. ( Al Deeb, S; Al Moutaery, K; Arshaduddin, M; Biary, N; Tariq, M, 2001) |
| "A Parkinsonian-like tremor can be induced by a combined application of chlorpromazine and pentobarbitone in cats." | 3.68 | Parkinsonian-like tremor induced by a combined application of chlorpromazine and pentobarbitone in cats with left-paw preference. ( Cankaya, A; Gepdiremen, A; Kutlu, N; Tan, U, 1992) |
| "A new less invasive treatment of tremor using MR guided focused ultrasound has started and is promising." | 2.49 | [Role of neurosurgical management in movement disorders other than Parkinson disease]. ( Taira, T, 2013) |
| "Children with primary dystonia and those with tremor can be treated with deep brain stimulation of the internal globus pallidus and thalamus, respectively." | 2.42 | Neurosurgical treatment of spasticity and other pediatric movement disorders. ( Albright, AL, 2003) |
| "Baclofen is the treatment of choice for spasticity and is usually given in doses of 30 to 80 mg/day, although higher doses may be used." | 2.37 | Multiple sclerosis. Current concepts in management. ( Giesser, B, 1985) |
| "Symptomatic treatment of Multiple Sclerosis (MS) is crucial, since it helps to lessen the limitations that affect patients' daily lives." | 1.91 | Effects of intrathecal Baclofen in reducing tremors in patients with multiple sclerosis. ( Aldarwish, WA; Ali, EN, 2023) |
| "Baclofen was largely ineffective in reducing withdrawal-induced tremors, although it was capable of producing sedation of a different type than that produced by phenobarbitol and ethanol." | 1.26 | The effects of ethanol, phenobarbital, and baclofen on ethanol withdrawal in the rhesus monkey. ( Tarika, JS; Winger, G, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (15.00) | 18.7374 |
| 1990's | 5 (25.00) | 18.2507 |
| 2000's | 6 (30.00) | 29.6817 |
| 2010's | 4 (20.00) | 24.3611 |
| 2020's | 2 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aldarwish, WA | 1 |
| Ali, EN | 1 |
| Sobstyl, M | 1 |
| Pasterski, T | 1 |
| Aleksandrowicz, M | 1 |
| Stapińska-Syniec, A | 1 |
| Taira, T | 1 |
| Kailainathan, R | 1 |
| Wong, A | 1 |
| Greene, S | 1 |
| Koutsogiannis, Z | 1 |
| Paterson, NE | 1 |
| Malekiani, SA | 1 |
| Foreman, MM | 1 |
| Olivier, B | 1 |
| Hanania, T | 1 |
| Quiñones Ortiz, L | 1 |
| Suárez Laurés, A | 1 |
| Pobes Martínez, A | 1 |
| de la Torre, M | 1 |
| Torres Lacalle, A | 1 |
| Forascepi Roza, R | 1 |
| Ruiz-Roso, G | 1 |
| Gomis, A | 1 |
| Fernández-Lucas, M | 1 |
| Díaz-Domínguez, M | 1 |
| Teruel-Briones, JL | 1 |
| Quereda, C | 1 |
| Albright, AL | 1 |
| Weiss, N | 1 |
| North, RB | 1 |
| Ohara, S | 1 |
| Lenz, FA | 1 |
| Puccioni-Sohler, M | 1 |
| Papais-Alvarenga, R | 1 |
| de Souza, PM | 1 |
| de França, SC | 1 |
| Gonçalves, RR | 1 |
| Jacobson, S | 1 |
| LeTourneau, JL | 1 |
| Hagg, DS | 1 |
| Smith, SM | 1 |
| Björkman, S | 1 |
| Lewander, T | 1 |
| Karlsson, JA | 1 |
| Koskinen, LO | 1 |
| Zetterström, T | 1 |
| Tarika, JS | 1 |
| Winger, G | 1 |
| Humeniuk, RE | 1 |
| White, JM | 1 |
| Ong, J | 1 |
| Tariq, M | 1 |
| Arshaduddin, M | 1 |
| Biary, N | 1 |
| Al Moutaery, K | 1 |
| Al Deeb, S | 1 |
| Tan, U | 2 |
| Gepdiremen, A | 2 |
| Kutlu, N | 2 |
| Cankaya, A | 2 |
| File, SE | 2 |
| Zharkovsky, A | 2 |
| Hitchcott, PK | 1 |
| Gulati, K | 1 |
| Giesser, B | 1 |
3 reviews available for baclofen and Action Tremor
| Article | Year |
|---|---|
[Role of neurosurgical management in movement disorders other than Parkinson disease].
Topics: Baclofen; Deep Brain Stimulation; Dystonia; Humans; Injections, Spinal; Movement Disorders; Muscle S | 2013 |
Neurosurgical treatment of spasticity and other pediatric movement disorders.
Topics: Athetosis; Baclofen; Child; Chorea; Dystonia; Electric Stimulation Therapy; GABA Agonists; Humans; I | 2003 |
Multiple sclerosis. Current concepts in management.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Baclofen; Dantrolene; Fatigue; Gastrointestina | 1985 |
17 other studies available for baclofen and Action Tremor
| Article | Year |
|---|---|
Effects of intrathecal Baclofen in reducing tremors in patients with multiple sclerosis.
Topics: Adult; Baclofen; Humans; Injections, Spinal; Male; Multiple Sclerosis; Muscle Relaxants, Central; Mu | 2023 |
Treatment of severe refractory dystonic tremor associated with cervical dystonia by bilateral deep brain stimulation: A case series report.
Topics: Aged; Baclofen; Benzodiazepines; Botulinum Toxins, Type A; Deep Brain Stimulation; Drug Resistance; | 2020 |
Recognition of gamma-hydroxybutyric acid withdrawal: Rapid progression and prolonged symptomatology.
Topics: Adult; Anti-Bacterial Agents; Australia; Baclofen; Benzodiazepines; Diazepam; Humans; Hydroxybutyrat | 2017 |
Pharmacological characterization of harmaline-induced tremor activity in mice.
Topics: Affect; Animals; Anticonvulsants; Baclofen; Behavior, Animal; Benzazepines; Carbolines; Chlordiazepo | 2009 |
Warning against unexpected medication in haemodialysis.
Topics: Acyclovir; Aged; Akathisia, Drug-Induced; Alcoholic Intoxication; Baclofen; Continuity of Patient Ca | 2011 |
Aciclovir and valaciclovir neurotoxicity in patients with renal failure.
Topics: Acyclovir; Akathisia, Drug-Induced; Baclofen; Continuity of Patient Care; Humans; Kidney Failure, Ch | 2012 |
Attenuation of cerebellar tremor with implantation of an intrathecal baclofen pump: the role of gamma-aminobutyric acidergic pathways. Case report.
Topics: Baclofen; Cerebellum; Female; GABA Agonists; gamma-Aminobutyric Acid; Humans; Infusion Pumps, Implan | 2003 |
Parkinsonism in the course of HTLV-I-associated myelopathy.
Topics: Antiparkinson Agents; Baclofen; Blotting, Western; Electromyography; Enzyme-Linked Immunosorbent Ass | 2005 |
Baclofen and gamma-hydroxybutyrate withdrawal.
Topics: Adjuvants, Anesthesia; Baclofen; Benzodiazepines; Delirium; Epilepsy; Female; GABA Agonists; Humans; | 2008 |
Thermic and tremorogenic effects of thyroliberin (TRH) in reserpine-treated mice--the non-involvement of GABA-ergic mechanisms.
Topics: Animals; Baclofen; Body Temperature Regulation; Dose-Response Relationship, Drug; Hydroxybutyrates; | 1981 |
The effects of ethanol, phenobarbital, and baclofen on ethanol withdrawal in the rhesus monkey.
Topics: Alcoholism; Animals; Ataxia; Baclofen; Behavior, Animal; Drug Interactions; Ethanol; Humans; Macaca | 1980 |
The effects of GABAB ligands on alcohol withdrawal in mice.
Topics: Animals; Baclofen; Behavior, Animal; Diazepam; Dose-Response Relationship, Drug; Ethanol; Female; GA | 1994 |
Baclofen attenuates harmaline induced tremors in rats.
Topics: Animals; Baclofen; Brain; Dose-Response Relationship, Drug; Drug Interactions; Electromyography; Ess | 2001 |
Parkinsonian-like tremor induced by a combined application of chlorpromazine and pentobarbitone in cats with left-paw preference.
Topics: Animals; Atropine; Baclofen; Biperiden; Cats; Chlorpromazine; Feedback; Female; Functional Lateralit | 1992 |
Effects of nitrendipine, chlordiazepoxide, flumazenil and baclofen on the increased anxiety resulting from alcohol withdrawal.
Topics: Animals; Anxiety; Baclofen; Chlordiazepoxide; Diazepam; Ethanol; Flumazenil; Interpersonal Relations | 1992 |
A simple tremor model induced by pentobarbitone in guinea pig.
Topics: Animals; Baclofen; Biperiden; Electromyography; Guinea Pigs; Pentobarbital; Transducers; Tremor | 1991 |
Effects of baclofen and nitrendipine on ethanol withdrawal responses in the rat.
Topics: Aggression; Animals; Anxiety; Baclofen; Diet; Dose-Response Relationship, Drug; Ethanol; Exploratory | 1991 |